These findings also suggest that EMP can affect GSIS through regulating the expression level of Vav2. Furthermore, recent studies also showed that VAV2 is associated with renal diseases and cardiovascular homeostasis (29, 30), which may be related to reduced cardiovascular risk in T2D. Here, VAV2 is linked to type 2 diabetes mellitus.